Eutectic-based liquid delivery system for creatine in food products
A novel eutectic-based delivery system for creatine, designed for liquid and semi-liquid food products, offering enhanced stability and solubility. Ideal for functional and sports nutrition applications, this system leverages food-grade components to create stable, transparent solutions.
Overview
The eutectic-based liquid delivery system for creatine is a cutting-edge innovation designed to enhance the solubility and stability of creatine in food products. This system leverages deep eutectic systems (DES), which are formed using food-grade components like organic acids, amino acids, and sugars, to create a stable, low-water environment. This approach allows creatine to be fully dissolved within the solution, providing a homogeneous and transparent liquid ideal for incorporation into various functional and sports nutrition products.
Technical specifications
Key features:
- Utilizes deep eutectic systems (DES) to dissolve creatine in stable liquid forms.
- Made from food-approved components, ensuring safety and compatibility with a wide range of food and beverage applications.
- Demonstrates prolonged stability, maintaining homogeneous liquids over months at ambient conditions.
- Adaptable to various formats, including beverages, gels, and dairy systems.
- No chemical reactions or unwanted by-products, allowing for efficient, scalable preparation.
Technology readiness level
This technology is currently at Technology Readiness Level 4. It has been experimentally validated in controlled environments, demonstrating the ability to form stable creatine-containing liquids. Future validation phases will focus on optimizing compositions, evaluating physicochemical stability, and testing in model food systems to ensure compatibility and regulatory compliance.
About Universidade NOVA de Lisboa
NOVA University Lisbon is a comprehensive public research institution spanning multiple campuses across the Lisbon metro area, combining selective excellence with an applied, collaborative ethos. Industry engages through co‑located laboratories at FCT NOVA and a science and technology park adjacent to the Caparica campus, alongside structured corporate partnership programs. Clinical translation is enabled by NOVA Medical School’s integration with Lisbon’s hospital network and clinical academic consortia, providing access to patient populations and real‑world settings. Research is supported by competitive European and Portuguese national funding, including Horizon Europe and the Foundation for Science and Technology, complemented by industry‑sponsored work. University‑wide innovation offices and school‑level TTOs provide IP, licensing, and startup support as a clear entry point for corporate R&D.
delivered to your inbox.